Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus

Virchows Archiv

Volumn 461, Issue 5, 2012, Pages 553-559

  Sahi, Helka ^a,b,d   Koljonen, Virve ^a   Kavola, Heli ^a   Haglund, Caj ^a   Tukiainen, Erkki ^a   Sihto, Harri ^c   Böhling, Tom ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Laboratory of Molecular Oncology   (Finland)

^d Toolo Hospital   (Finland)

Author keywords

Apoptosis; Bcl 2; Merkel cell carcinoma; Merkel cell polyomavirus

Indexed keywords

PROTEIN BCL 2; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOCAL METASTASIS; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MERKEL CELL POLYOMAVIRUS; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR VIRUS INFECTIONS;

EID: 84871614948     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1310-3     Document Type: Article

References (35)

1. Koljonen V, Bohling T, Granhroth G, Tukiainen E (2003) Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 229:607-610 (Pubitemid 37121763)
2. Koljonen V, Tukiainen E, Haglund C, Bohling T (2006) Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma. Anticancer Res 26:2209-2212 (Pubitemid 43980173)
3. Houben R, Schrama D, Becker JC (2009) Molecular pathogenesis of Merkel cell carcinoma. Exp Dermatol 18:193-198
4. Kennedy MM, Blessing K, King G, Kerr KM (1996) Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study. Am J Dermatopathol 18:273-277 (Pubitemid 26230852)
5. Feinmesser M, Halpern M, Fenig E, Tsabari C, Hodak E, Sulkes J et al (1999) Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome? Hum Pathol 30:1367-1372 (Pubitemid 29534301)
6. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
7. Kim J, McNiff JM (2008) Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma. Mod Pathol 21:764- 769 (Pubitemid 351744848)
8. Arora R, Shuda M, Guastafierro A, Feng H, Toptan T, Tolstov Yet al (2012) Survivin is a therapeutic target in merkel cell carcinoma. Sci Transl Med 4:133ra56
9. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100 (Pubitemid 351300792)
10. Kassem A, Schopflin A, Diaz C, Weyers W, Stickeler E, Werner M et al (2008) Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 68:5009-5013
11. Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, Schrama D (2009) MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 129:248-250
12. Sahi H, Kukko H, Böhling T, Tukiainen E, Sihto H, Joensuu H et al (2010) Unusually young Merkel cell carcinoma patients are Merkel cell polyomavirus positive and frequently immunocompromised. Eur J Plast Surg 33:349-353
13. Koljonen V, Kukko H, Pukkala E, Sankila R, Bohling T, Tukiainen E et al (2009) Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 101:1444-1447
14. Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P (2009) Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 129:246-248
15. Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010) Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer 126:2240-2246
16. Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 17:4806-4813
17. Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2209) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938- 945
18. Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A 83:5214-5218 (Pubitemid 16051345)
19. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336 (Pubitemid 120029101)
20. Leverkus M, Diessenbacher P, Geserick P (2008) FLIP ing the coin? Death receptor-mediated signals during skin tumorigenesis. Exp Dermatol 17:614-622 (Pubitemid 351803084)
21. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620 (Pubitemid 27264969)
22. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y (1994) Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 54:6-8 (Pubitemid 24042076)
23. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB et al (1993) bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694 (Pubitemid 23252262)
24. Hintze J (2009) NCSS, NCSS, LLC. Kaysville, Utah. www.ncss.com
25. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6 (Pubitemid 24054605)
26. Moll I, Gillardon F, Waltering S, Schmelz M, Moll R (1996) Differences of bcl-2 protein expression between Merkel cells and Merkel cell carcinomas. J Cutan Pathol 23:109-117 (Pubitemid 26108748)
27. Su LD, Fullen DR, Lowe L, Uherova P, Schnitzer B, Valdez R (2002) CD117 (KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 24:289-293 (Pubitemid 34810303)
28. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619 (Pubitemid 23259742)
29. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS et al (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 105:16272-16277
30. Olavarrieta L, Hernandez P, Krimer DB, Schvartzman JB (2002) DNA knotting caused by head-on collision of transcription and replication. J Mol Biol 322:1-6 (Pubitemid 36132666)
31. Pipas JM, Levine AJ (2001) Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 11:23-30 (Pubitemid 32222748)
32. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
33. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602:73-87 (Pubitemid 34311901)
34. Houben R, Schrama D, Alb M, Pfohler C, Trefzer U, Ugurel S et al (2010) Comparable expression and phosphorylation of the retinoblastoma protein in Merkel cell polyoma viruspositive and negative Merkel cell carcinoma. Int J Cancer 126:796-798
35. (2010) Merkel cell carcinoma. In: Edge SB, Byrd DR, Compton CC, et al. (eds) AJCC cancer staging manual, 7th ed. Springer, New York, 315-323